Quarterly report pursuant to Section 13 or 15(d)

ACQUISITIONS - Schedule of identifiable assets acquired and liabilities assumed (Details)

v3.22.2.2
ACQUISITIONS - Schedule of identifiable assets acquired and liabilities assumed (Details) - USD ($)
$ in Thousands
Sep. 30, 2022
Apr. 30, 2022
Dec. 31, 2021
Sep. 30, 2021
Dec. 31, 2020
Business Combination, Separately Recognized Transactions [Line Items]          
Goodwill $ 8,079   $ 2,068 $ 2,068 $ 2,068
Kind Therapeutics USA LLC.          
Business Combination, Separately Recognized Transactions [Line Items]          
Current assets, net of cash acquired   $ 5,047      
Property and equipment   622      
Goodwill   6,011      
Current liabilities   (511)      
Fair value of net assets acquired   17,952      
Kind Therapeutics USA LLC. | Tradename and trademarks          
Business Combination, Separately Recognized Transactions [Line Items]          
Intangible assets:   2,041      
Kind Therapeutics USA LLC. | Licenses and customer base          
Business Combination, Separately Recognized Transactions [Line Items]          
Intangible assets:   4,700      
Kind Therapeutics USA LLC. | Non-compete agreements          
Business Combination, Separately Recognized Transactions [Line Items]          
Intangible assets:   $ 42